Bockhorst K, Hoehn-Berlage M, Kocher M, Hossmann K A
Max-Planck-Institut für neurologische Forschung, Abteilung für experimentelle Neurologie, Cologne, Federal Republic of Germany.
Acta Neurochir Suppl (Wien). 1990;51:134-6. doi: 10.1007/978-3-7091-9115-6_45.
In the experimental F98 rat glioma model the nuclear magnetic resonance contrast agent MnTPPS was used to increase the contrast between tumour and peritumourous brain tissue. By evaluating pre- and postcontrast CPMG echo trains after different dose and circulation times of MnTPPS, the transverse relaxation time T2, the magnetization extrapolated to the time zero M (0), and the contrast ratio Rc of the magnetizations in neoplastic and normal tissues were determined. According to these data a maximum contrast is obtained a few hours after injection of 0.25 mmol MnTPPS/kg bw, using spin echo pulse sequences with short repetition times TR (1,100 ms), and short spin echo time TE (25 ms).
在实验性F98大鼠胶质瘤模型中,使用核磁共振造影剂MnTPPS来增加肿瘤与瘤周脑组织之间的对比度。通过评估在不同剂量和循环时间的MnTPPS后对比前后的CPMG回波序列,测定了横向弛豫时间T2、外推至时间零点的磁化强度M(0)以及肿瘤组织和正常组织中磁化强度的对比度Rc。根据这些数据,注射0.25 mmol MnTPPS/kg体重后数小时,使用短重复时间TR(1,100 ms)和短自旋回波时间TE(25 ms)的自旋回波脉冲序列可获得最大对比度。